Analyst Remains Confident In Corium Despite Bad FDA News
December 27, 2017 at 11:19 AM EST
The U.S. Food and Drug Administration sent an unfavorable Complete Response Letterlast week to Agile Therapeutics Inc (NASDAQ: ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|